NephroQuiz: muscles and bananas.
Published in Healthcare & Nursing, Genetics & Genomics, and General & Internal Medicine
A 40-year-old African American man arrived at the emergency room experiencing profound muscle weakness. Past medical history revealed sporadic muscle tightness occurring 1-3 times per week, alleviated by consuming bananas. He was not using any medications, and his family history was noteworthy for hyperthyroidism and episodes of hypokalemia in his brother and mother.
Upon presentation, vital signs were temperature 98.4°F, blood pressure 127/83 mmHg, heart rate 111 beats/minute, respiratory rate 11 breaths/ minute, and oxygen saturation 96% on room air. Physical examination revealed pronounced weakness in both upper and lower extremities (strength assessed at 0/5) with areflexia.
Laboratory results are shown in Table 1. The electrocardiogram demonstrated sinus tachycardia with prolonged QTc interval of 606 ms. Swift replacement of hypokalemia effectively alleviated his symptoms, albeit leading to transient hyperkalemia that spontaneously resolved.
|
|
||
|
Tests |
Results |
Normal range |
|
Sodium |
139 mmol/L |
132-148 mmol/L |
|
Potassium |
<1.5 mmol/L |
3.5-5 mmol/L |
|
Chloride |
105 mmol/L |
98-111 mmol/L |
|
Bicarbonate |
21 mmol/L |
23-32 mmol/L |
|
Blood Urea Nitrogen |
18 mg/dL |
10-25 mg/dL |
|
Creatinine |
0.91 mg/dL |
0.7-1.4 mg/dL |
|
Calcium |
9.3 mg/dL |
8.4-10.5 mg/dL |
|
Albumin |
3.9 g/dL |
3.5-5.0 g/dL |
|
Total protein |
7.2 g/dL |
6.6-8.7 g/dL |
|
Glucose |
90 mg/dL |
65-100 mg/dL |
|
Magnesium |
1.9 mg/dL |
1.6-2.6 mg/dL |
|
Phosphorus |
2.1 mg/dL |
2.5-4.5 mg/dL |
|
AST |
64 U/L |
5-40 U/L |
|
ALT |
153 U/L |
5-41 |
|
Bilirubin- total |
0.3 mg/dL |
0.2-1.2 mg/dL |
|
Alkaline phosphatase |
79 U/L |
40-129 U/L |
|
Random urine K/Cr ratio |
10.7 mmol/g Cr |
17-121 mmol/g Cr |
|
TSH |
< 0.006 mcIU/mL |
0.270-4.200 mcIU/mL |
|
Free T3 |
13.0 pg/mL |
2.1-4.4 pg/mL |
|
Free T4 |
3.04 ng/dL |
0.9-1.70 ng/dL |
|
Thyroid Stimulating Ig (TSI) |
3.43 IU/L |
<=0.54 IU/L |
|
Thyroid Peroxidase Ab |
62.6 IU/mL |
0.0-9.0 IU/mL |
The correct answer, link to published case and explanation will be provided in the comment section.
Click here to read the original case report, published in BMC Nephrology. We encourage discussion of the case and questions in the comments.
Follow the Topic
-
BMC Nephrology
This is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Your space to connect: The Primary immunodeficiency disorders Hub
A new Communities’ space to connect, collaborate, and explore research on Clinical Medicine, Immunology, and Diseases!
Continue reading announcementRelated Collections
With Collections, you can get published faster and increase your visibility.
Lifestyle modifications for preventing kidney disease
BMC Nephrology invites new submissions on Lifestyle modifications for preventing kidney disease.
Chronic kidney disease (CKD) is a significant public health challenge, with lifestyle factors playing a crucial role in its prevention and management. Lifestyle modifications, including dietary changes, physical activity, weight management, and smoking cessation, have been identified as important strategies for reducing the risk of kidney disease and slowing its progression. Research in this area has highlighted the impact of lifestyle interventions on kidney health, emphasizing the potential for preventive measures to alleviate the burden of CKD.
Recent advances demonstrate the effectiveness of lifestyle interventions in reducing the risk of CKD and improving outcomes for individuals with kidney disease. Additionally, research has underscored the importance of multidisciplinary approaches that integrate lifestyle modifications into routine clinical care, promoting holistic kidney health.
Looking ahead, continued research in this area holds the potential for identifying personalized lifestyle interventions tailored to individual risk factors and cultural contexts. Furthermore, ongoing research efforts may lead to the development of innovative digital health tools and mobile applications that support individuals in adopting and sustaining healthy lifestyle behaviors to prevent kidney disease.
Topics of interest include, but are not limited to:
• Dietary interventions for kidney disease prevention
• Exercise and physical activity in CKD management
• Smoking cessation and its impact on kidney health
• Lifestyle modifications for reducing blood pressure and preventing CKD
• The role of mindfulness and stress reduction techniques in preventing kidney disease
• Impact of sleep quality and duration on kidney health
• Evaluating the effectiveness of community-based lifestyle interventions in preventing CKD
• Exploring the influence of socioeconomic factors on lifestyle modifications and kidney disease prevention
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Dec 12, 2025
Vascular control and renal blood flow regulation
BMC Nephrology is calling for submissions to our Collection on Vascular control and renal blood flow regulation.
This Collection aims to explore the intricate relationships between vascular control and renal blood flow regulation, highlighting current research and advancements in this critical area.
Advances in the field have significantly enhanced our understanding of renal vascular dynamics and their implications for various kidney disorders, such as hypertension, chronic kidney disease, and acute kidney injury. Recent studies have focused on the molecular pathways involved in renal perfusion regulation, including the role of nitric oxide, prostaglandins, and endothelial function. By unraveling these complex interactions, researchers have begun to develop novel therapeutic strategies aimed at improving renal blood flow and preventing renal injury, thereby enhancing patient outcomes.
Future research in this domain holds promise for identifying new biomarkers and therapeutic targets that can lead to more effective interventions for renal diseases. As our understanding of renal circulation deepens, it is likely that innovative approaches will emerge, such as personalized medicine strategies that account for individual variations in renal vascular responses. Additionally, advancements in imaging techniques and computational modeling may provide unprecedented insights into renal blood flow regulation, facilitating better clinical decision-making.
Topics of interest include, but are not limited to:
Mechanisms of renal blood flow regulation
Impact of renal vascular dynamics on kidney disease
Role of endothelial function in renal perfusion
Advances in renal circulation imaging
This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being).
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Mar 19, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in
The correct answer is explained below:
.
.
.
.
.
The correct answer is: hypokalemic periodic paralysis.
Periodic paralysis (PP) is a rare channelopathy marked by recurrent episodes of flaccid skeletal muscle paralysis. Hypokalemic periodic paralysis (HypoPP) is categorized into familial or acquired forms. Triggers for episodes of HypoPP are primarily associated with intense exercise and high carbohydrate intake, and less frequently related to viral infections, stress, cold, salt consumption, and medications (such as glucocorticoids and insulin).
Familial HypoPP is associated with variants in the skeletal muscle sodium channel gene SCN4A in 20% of patients or the L-type calcium channel gene CACNA1S in 60% of patients. The majority of reported pathogenic variants involve arginine residues in S4 transmembrane segments, with notable hotspots at codons R528 and R1239. Generally, the existence of hyperthyroidism is more strongly associated with a diagnosis of acquired thyrotoxic periodic paralysis (TPP), with most cases occurring in Asian males without a family history of the condition. Pathogenic variants in KCNJ2 and KCNJ18 are associated with susceptibility to TPP. KCNJ2 and KCNJ18 encode Kir 2.1 and Kir2.6 respectively, inwardly rectifying potassium channels expressed in skeletal muscle and transcriptionally regulated by thyroid hormone.
Genetic testing in the discussed patient revealed a heterozygous pathogenic variant in CACNA1S [c.1583 G>A (p. R528H)] and normal sequencing of SCN4A, KCNJ2 and KCNJ18. The patient received a diagnosis of familial hypokalemic periodic paralysis and concurrent hyperthyroidism due to Graves’ disease. The likelihood of TPP in this case is reduced, given the patient is not of Asian descent, has a family history of HypoPP, and lacks identifiable variants in KCNJ2 and KCNJ18. The pathogenic variant observed in this case has been documented previously. This variant leads to a substantial reduction in the whole-cell calcium channel current and induces depolarization of the resting cell potential in response to hypokalemia.
Management of acute paralytic episodes involves maintaining proper control of serum potassium levels, necessitating vigilant monitoring for post-treatment hyperkalemia. Lifestyle and dietary modifications to avoid triggering factors are integral to treatment. Although the precise mechanism is not fully elucidated, carbonic anhydrase inhibitors have demonstrated efficacy in reducing the frequency of familiar HypoPP episodes. There is variability in the response to carbonic anhydrase inhibitors based on genotype; individuals with CACNA1S variants tend to exhibit a more favorable response compared to SCN4A variants. Additionally, the incorporation of a potassium-sparing diuretic, either in conjunction with carbonic anhydrase inhibitors or as a standalone treatment, may offer advantages for specific patients.
Read more in the published article: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-024-03749-x
Read more in the published article: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-024-03749-x